Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19
Case Presentation An 18-year-old man presented for psychiatric evaluation with complaints of “I’ve been anxious, irritated and sad most of the time…” and “…inability to get motivated/concentrate and retain information.” Other Symptoms Mentioned Medical History Timeline Of Clinical Case History Clinical Exam Diagnosis Treatment Follow Up 1 Week Later After 3 Weeks At 4 Weeks […]
Seizures as Primary Manifestation of Pediatric COVID-19
A systematic retrospective study established that seizures occur early and could be the primary manifestation of acute COVID-19 in children. The study included 175 children aged 6 months to 17 years, infected with COVID-19 out of which 11 had presented with seizures. It was found that these children may lack fever or other typical symptoms […]
Hypolipidemia is associated with the severity of COVID-19
A study investigated pathological alteration in plasma lipid levels of COVID-19 patients. LDL-c and TC levels were significantly lower in COVID-19 patients as compared with normal subjects. Significant and gradual decreases in levels of LDL-c and TC were observed in all patients. HDL-c levels only decreased significantly in critical cases as compared with levels in […]
Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
COVID-19 and related cardio-renal-pulmonary damage can profoundly affect the cardiovascular risk management of people with diabetes. It is recommended to continue ACE inhibitors and angiotensin receptor blockers, both SGLT2 inhibitors and GLP-1 receptor agonists have anti-inflammatory activities, which might be beneficial for patients with COVID-19. However, several expert groups in diabetes have previously advised that […]